Evidence supporting the use of: RNA & DNA
For the health condition: Infection (viral)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

RNA and DNA therapies are scientifically validated for the treatment and prevention of certain viral infections, though the degree of evidence varies by context. The most prominent example is the use of messenger RNA (mRNA) in vaccines, such as those developed for COVID-19 by Pfizer-BioNTech and Moderna. These vaccines use synthetic mRNA encoding viral proteins (e.g., the SARS-CoV-2 spike protein) to stimulate an immune response without causing disease. Clinical trials and real-world studies have demonstrated high efficacy and safety, leading to emergency use and full approvals from regulatory agencies worldwide.

Additionally, research is ongoing into RNA-based therapeutics, such as small interfering RNA (siRNA) and antisense oligonucleotides, for targeting viral genomes or host factors essential for viral replication. Some antisense therapies have been approved for non-viral diseases, and trials are underway for viral infections, but widespread clinical use for most viral infections is still in development.

Oral or injectable supplementation with isolated nucleic acids (RNA/DNA) as general immune boosters for viral infections lacks robust scientific support. Historical use in this context is minimal, and evidence is sparse. However, the use of nucleic acid-based biotechnology, especially mRNA vaccines, represents a major advance in infectious disease management with substantial scientific validation.

More about RNA & DNA
More about Infection (viral)

Other health conditions supported by RNA & DNA

Cancer (prevention)
Infection
Infection (viral)

Products containing RNA & DNA

We currently have no products on Vitabase that contain this ingredient.